- MENU
- HOME
- SEARCH
- WORLD
- MAIN
- AFRICA
- ASIA
- BALKANS
- EUROPE
- LATIN AMERICA
- MIDDLE EAST
- United Kingdom
- United States
- Argentina
- Australia
- Austria
- Benelux
- Brazil
- Canada
- China
- France
- Germany
- Greece
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Korea
- Mexico
- New Zealand
- Pakistan
- Philippines
- Poland
- Russia
- South Africa
- Spain
- Taiwan
- Turkey
- USA
- BUSINESS
- WEALTH
- STOCKS
- TECH
- HEALTH
- LIFESTYLE
- ENTERTAINMENT
- SPORTS
- iHaveNet.com: United States
The biotech industry has experienced a significant rally in stock values in recent years, leading to concerns about a potential bubble. Here are some key points from the search results:
In 2014, the fastest start to a year for US biotech initial public offerings stoked fears of a bubble, with concerns that investors were taking risks on overvalued companies.
In 2015, the Wall Street Journal reported on fears of a bubble in the biotech industry, citing the dramatic rise in stock values in the sector.
In 2019, short sellers highlighted bubble fears in South Korea's biotech industry, with concerns about overvalued companies and a near-halving in sector value since the previous year.
In 2020, private biotech firms raised record-breaking sums of funding, leading to concerns about biotech bubbles during the global recession.
In 2021, Evaluate Vantage reported that the biotech bull market was over, with a new analysis showing that the bubble had burst for biotech stocks.
One of the contributors to the overheated biotech market was investors' fears of missing out during the rapid rise in valuations that led to the bubble crunch.
In conclusion, the biotech industry has experienced a significant rally in stock values in recent years, leading to concerns about a potential bubble. While the industry has seen periods of growth and decline, investors and analysts continue to monitor the market closely for signs of overvaluation and potential risks.
More Investing News & Investment Analysis ...
- How to Keep Calm in a Volatile Market
- Kraft, Heinz Agree to Form Food Giant
- Biotech Rally Fuels Bubble Fears
- Investing In Commodities
- Dollar / Shares Correlation Reverses
- Negative Rates: An Investor's Perspective
- The Case for Alternative Investments
- Use Volatility to Your Advantage With 'Black Belt' Investing
- Preferred Stocks Beat Bonds as Interest Rates Face Upward Pressure
- How to Prepare for the Next Bear Market
- Socially Responsible Investing: Risks and Traps
- What Is Contrarian Investing?
- UBS Advisor Ron Vinder on ETF Investment
- How to Invest Defensively with ETFs
- Sector ETFs As Single Stock Replacements
"Biotech's Rally Fuels Bubble Fears "